Abirateronen 250mg Tab In Stock
Anti-cancer

Abirateronen 250mg Tab

Abiraterone 250 mg Tablet is an oral medication used in the treatment of prostate cancer. It works by reducing the production of male hormones (androgens) in the body, which helps to slow down or stop the growth of cancer cells that rely on these hormones to multiply.

This medicine is generally prescribed along with prednisone or prednisolone to improve its effectiveness and reduce certain side effects.
It is usually taken once daily on an empty stomach, as directed by your healthcare professional.

Product Details

Key Benefits

  • Helps manage advanced or metastatic prostate cancer when prescribed as part of an appropriate treatment plan
  • Helps reduce the production of androgen hormones, including testosterone, which can support the management of hormone-sensitive prostate cancer
  • May help slow the growth and progression of prostate cancer in appropriate patients
  • Can be used as part of a comprehensive treatment regimen to support disease control and quality of life
  • May be prescribed in combination with other medicines, such as a corticosteroid, depending on the patient's condition and treatment plan

Key Ingredients

Abiraterone Acetate – The active pharmaceutical ingredient. It inhibits CYP17, an enzyme involved in androgen production, thereby reducing the production of testosterone and other androgens that can contribute to the growth of certain prostate cancer cells.
Pharmaceutical Excipients – Inactive ingredients used to maintain the medicine's stability, quality, formulation, and proper drug delivery.

Recommended Usage

  • Dosage: Take only as prescribed by your oncologist or healthcare professional.
  • Abiraterone is commonly taken once daily, according to the prescribed dosage.
  • Take the tablet on an empty stomach. Do not eat for at least 2 hours before taking the medicine and for at least 1 hour after taking it.
  • Swallow the tablet whole with water. Do not crush, chew, or break the tablet.
  • Take the medicine at approximately the same time each day for consistent treatment.
  • Take any accompanying corticosteroid medication exactly as prescribed by your doctor.
  • Do not change the dosage or stop treatment without consulting your healthcare professional.

Safety Information

  • Use only under the supervision of an oncologist or qualified healthcare professional.
  • Regular monitoring of liver function, blood pressure, potassium levels, and fluid retention may be required during treatment.
  • Inform your doctor if you have liver disease, high blood pressure, heart problems, low potassium levels, or a history of cardiovascular disease.
  • Abiraterone may cause or worsen high blood pressure, low potassium, fluid retention, or liver-related problems, so regular medical monitoring is important.
  • Inform your healthcare professional about all medicines and supplements you are currently taking, as drug interactions may occur.
  • Pregnant women or women who may become pregnant should not handle crushed or broken tablets without appropriate protective measures.
  • Men receiving treatment should follow their healthcare professional's advice regarding contraception and pregnancy precautions.
  • Store below 30°C in a cool, dry place away from direct sunlight and moisture, according to the product label.
  • Keep out of reach of children and pets.

Disclaimer

Abiraterone Acetate is a prescription anticancer medicine used in the management of certain forms of advanced or metastatic prostate cancer. It should be used only under the supervision of a qualified oncologist or healthcare professional.
Treatment with Abiraterone may require combination therapy and regular monitoring of liver function, blood pressure, potassium levels, and other clinical parameters. It is not intended for self-medication.
Individual treatment response may vary depending on the patient's cancer type, stage, overall health, and treatment plan. Always follow your oncologist's instructions regarding dosage, duration, monitoring, and accompanying medicines.